Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical testosterone for bone health and sexual function in menopausal women on estrogen therapy
ACTRN12621001100886Phase 4Active, not recruiting
- Sponsor
- Monash University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis, sexual dysfunction, ovarian hypofunction (POI) and 2 more comparing Testosterone cream with Placebo cream (2 arms). Primary endpoint: Total hip bone mineral density. Started Feb 2022; status: active, not recruiting.
02
Drugs
testosterone
03
Conditions
osteoporosissexual dysfunctionovarian hypofunction (POI)early menopause (POI)menopause
Beyond the preview
Go deeper on ACTRN12621001100886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001100886.